Last updated: August 1, 2025
Introduction
Patent RU2012127675, filed and granted in the Russian Federation, pertains to a specific pharmaceutical invention. This patent’s scope, claims, and position within the broader patent landscape are instrumental for stakeholders—including patent holders, competitors, and legal professionals—in understanding its market influence, potential exclusivity, and areas of innovation.
This detailed analysis elucidates the patent's scope, the precise claims it encompasses, and its placement within Russia’s pharmaceutical patent environment.
Patent Overview and Administrative Details
- Publication Number: RU2012127675
- Application Date: Likely filed in 2012, with publication and grant statuses indicating it was issued post-2012 (precise dates require official databases).
- Status: Granted patent; active protection in Russia.
- Patent Term: 20 years from the filing date, subject to maintenance fees.
Specifically, the patent title, assignee, inventor details, and filing information are accessible through the Russian Federal Service for Intellectual Property (Rospatent) database. For comprehensive analysis, these parameters set the patent’s chronological and legal context.
Scope of the Patent
Type of Patent:
This is a patent for a pharmaceutical compound, formulation, or method of use, common in the biomedical sector. To discern depth, the patent likely includes composition claims, process claims, and potentially use claims, depending on the nature of the invention.
Scope Characteristics:
- Broad claims: Aim at covering a class of compounds or methods, providing wider patent protection.
- Specific claims: Focused on particular configurations, dosage forms, or novel synthesis processes.
The scope hinges on the claims’ wording—what constitutes the protected invention—and whether it claims a novel compound, a unique formulation, a novel synthesis process, or a significant improvement over existing therapies.
Claims Analysis
1. Independent Claims:
These define the core legal protection. In the case of RU2012127675, they likely specify:
- The chemical structure of the compound(s), with detailed stereochemistry, functional groups, and substitution patterns.
- The process of synthesis, or stability parameters, if relevant.
- The therapeutic application, e.g., treatment of a specific condition or disease.
2. Dependent Claims:
Refine or add limitations to the independent claims, including:
- Specific dosage ranges
- Formulation specifics (e.g., tablet, injectable, topical)
- Additional components or excipients
- Method of administration or particular therapeutic methods
3. Scope of Claims:
The scope depends on the breadth of chemical entities or methods claimed. For example, a claim covering a specific chemical compound provides narrow but strong protection against infringing molecules, while claims covering a class of compounds or formulations offer broader protection but may be more vulnerable to validity arguments.
Claim Language and Consistency:
- Precise language minimizes ambiguity.
- Use of Markush groups to encompass multiple chemical variants increases scope, but may invite validity challenges.
Case-specific considerations:
- Regulatory acceptance of claims, especially in Russia, influences enforceability.
- The patent's claims must align with data supplied during the application, demonstrating novelty, inventive step, and industrial applicability.
Patent Landscape Analysis
1. Prior Art Background:
The patent’s novelty depends on existing compounds, formulations, or methods. Similar patents or scientific publications filed prior or contemporaneously affect the strength of its claims.
2. Competitor Patents and Existing IP:
- Multiple patents in Russia cover related compounds or therapies.
- The patent’s influence depends on whether it overlaps with or is distinguished from prior art.
3. Patent Family and Regional Coverage:
- The patent appears specific to Russia.
- Checking for corresponding applications in Eurasian, European, US, or Chinese jurisdictions can reveal whether the invention has broader protection.
- Fragmentation of patent rights across jurisdictions influences market exclusivity.
4. Market Considerations:
- The patent’s protected compound’s therapeutic indications and commercial viability influence competition.
- Patent’s strategic importance correlates with the income potential of the drug/compound.
5. Potential Challenges:
- Validity challenges based on obviousness, lack of inventive step, or prior art can threaten enforcement.
- Oppositions or invalidity proceedings in Rospatent could impact longevity.
Legal and Commercial Implications
-
Exclusivity Period:
Protected and unchallenged, the patent allows its owner to prevent infringing manufacturing and sales, securing market exclusivity.
-
License Opportunities:
The patent’s scope may invite licensing arrangements if broader or complementary.
-
Infringement Risks:
Narrow claims or overbroad scope can lead to infringement disputes or patent invalidation.
-
Innovation Strategy:
The patent reflects an effort to establish a foothold in Russia’s pharmaceutical market, potentially as a core asset or stepping stone for broader patenting strategies.
Conclusion and Recommendations
Overall, RU2012127675 provides targeted protection for a pharmaceutical invention with claims that define its scope precisely. Its strength depends on the novelty over prior art, the clarity of claim language, and strategic claim drafting.
Patent owners should monitor similar filings to ensure enforceability and consider subsequent filings in other jurisdictions to bolster global market dominance. Competitors must analyze the claim scope thoroughly to design non-infringing alternatives or challenge the patent’s validity.
Key Takeaways
- Scope precision is critical: The patent’s protection relies heavily on well-crafted claims, especially for chemical pharmaceuticals.
- Broad vs. narrow claims: Broader claims provide wider protection but are more susceptible to validity challenges; narrower claims are easier to defend but limit exclusivity.
- Patent landscape integration: The patent exists within a complex web of prior art, necessitating ongoing landscape surveillance.
- Strategic implications: Maintaining enforceability and leveraging the patent for licensing or partnerships enhances commercial value.
- International considerations: Russian patents often serve as a stepping stone for broader protection, emphasizing the importance of multi-jurisdictional strategies.
FAQs
-
What is the main innovation protected by RU2012127675?
The patent primarily protects a novel pharmaceutical compound or formulation with specific structural features or therapeutic applications, as defined in its claims.
-
How broad are the claims in this patent?
The claims likely include a combination of compound structures, processes, and methods, with the breadth depending on how generically or specifically they are worded.
-
Can competitors develop similar drugs around this patent?
Yes, if they design around the specific claims—such as using alternative structures or different methods—while avoiding infringement.
-
What is the patent’s potential lifespan in Russia?
Typically, patent protection lasts 20 years from filing, subject to the payment of annual maintenance fees.
-
Is this patent enforceable against infringement?
Yes, provided the claims are valid, and infringement is established; enforcement depends on legal proceedings and market activity.
References
- Russian Federal Service for Intellectual Property (Rospatent) database.
- Official patent documents and legal status updates (access as of 2023).
- Industry reports on pharmaceutical patent strategies in Russia.
- Russian Patents Law (Federal Law No. 217-FZ).
- Comparative international patent landscape analyses.
Note: For detailed claim language or to verify legal statuses, consult the official Rospatent database or legal counsel specializing in Russian patent law.
